

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 6.30284765 |
| 2 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.88201443 |
| 3 | cellular extravasation (GO:0045123) | 5.67081071 |
| 4 | response to peptidoglycan (GO:0032494) | 5.57174497 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.46527756 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.46527756 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 5.46527756 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.46527756 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 5.46527756 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.46527756 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.06889257 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.84635194 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.82086763 |
| 14 | microglial cell activation (GO:0001774) | 4.80418510 |
| 15 | detection of external biotic stimulus (GO:0098581) | 4.72128424 |
| 16 | macrophage activation (GO:0042116) | 4.63461482 |
| 17 | detection of other organism (GO:0098543) | 4.46777456 |
| 18 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.45329654 |
| 19 | neutrophil mediated immunity (GO:0002446) | 4.37279485 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 4.34361652 |
| 21 | detection of biotic stimulus (GO:0009595) | 4.32502341 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.22919230 |
| 23 | response to host immune response (GO:0052572) | 4.17843005 |
| 24 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.17843005 |
| 25 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 4.03724418 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.02445933 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 3.84288747 |
| 28 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.83538443 |
| 29 | response to host (GO:0075136) | 3.83538443 |
| 30 | response to host defenses (GO:0052200) | 3.83538443 |
| 31 | negative regulation of cell killing (GO:0031342) | 3.78908125 |
| 32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.78908125 |
| 33 | myeloid leukocyte mediated immunity (GO:0002444) | 3.74655504 |
| 34 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.73844502 |
| 35 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.57747762 |
| 36 | detection of bacterium (GO:0016045) | 3.57042222 |
| 37 | neutrophil activation (GO:0042119) | 3.54320114 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.51137094 |
| 39 | response to muramyl dipeptide (GO:0032495) | 3.49263958 |
| 40 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.46434623 |
| 41 | myeloid cell activation involved in immune response (GO:0002275) | 3.46407430 |
| 42 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.46088511 |
| 43 | T-helper 1 type immune response (GO:0042088) | 3.44267826 |
| 44 | dosage compensation (GO:0007549) | 3.44037849 |
| 45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.43201374 |
| 46 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.40789199 |
| 47 | granulocyte activation (GO:0036230) | 3.35438260 |
| 48 | defense response to protozoan (GO:0042832) | 3.35101736 |
| 49 | regulation of macrophage cytokine production (GO:0010935) | 3.34230365 |
| 50 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.33901987 |
| 51 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.30223999 |
| 52 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.30223999 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.27118941 |
| 54 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.25446669 |
| 55 | negative regulation of B cell mediated immunity (GO:0002713) | 3.20564008 |
| 56 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.20564008 |
| 57 | germinal center formation (GO:0002467) | 3.20449490 |
| 58 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.19997052 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.17917726 |
| 60 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.16359645 |
| 61 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.10020410 |
| 62 | respiratory burst (GO:0045730) | 3.08267130 |
| 63 | negative regulation of interleukin-17 production (GO:0032700) | 3.05936849 |
| 64 | positive regulation of mast cell activation (GO:0033005) | 3.04809315 |
| 65 | response to protozoan (GO:0001562) | 3.03935835 |
| 66 | negative regulation of T cell mediated immunity (GO:0002710) | 2.98401727 |
| 67 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.98067105 |
| 68 | neutrophil chemotaxis (GO:0030593) | 2.97589897 |
| 69 | regulation of mast cell degranulation (GO:0043304) | 2.95121577 |
| 70 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.94799218 |
| 71 | regulation of mast cell activation (GO:0033003) | 2.94311502 |
| 72 | positive regulation of interferon-alpha production (GO:0032727) | 2.94102138 |
| 73 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.92705864 |
| 74 | cytokine secretion (GO:0050663) | 2.91700564 |
| 75 | cellular response to ethanol (GO:0071361) | 2.90939780 |
| 76 | B cell receptor signaling pathway (GO:0050853) | 2.90859567 |
| 77 | negative regulation of B cell proliferation (GO:0030889) | 2.90581390 |
| 78 | neutrophil migration (GO:1990266) | 2.89839025 |
| 79 | negative regulation of interleukin-6 production (GO:0032715) | 2.89608891 |
| 80 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.87149799 |
| 81 | response to manganese ion (GO:0010042) | 2.86603862 |
| 82 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.86162021 |
| 83 | I-kappaB phosphorylation (GO:0007252) | 2.85704040 |
| 84 | regulation of interferon-alpha production (GO:0032647) | 2.85257269 |
| 85 | hepatocyte apoptotic process (GO:0097284) | 2.84269891 |
| 86 | positive regulation of macrophage cytokine production (GO:0060907) | 2.84002411 |
| 87 | myeloid leukocyte activation (GO:0002274) | 2.82030987 |
| 88 | regulation of necroptotic process (GO:0060544) | 2.81927189 |
| 89 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.80808404 |
| 90 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.80758448 |
| 91 | tolerance induction (GO:0002507) | 2.77414465 |
| 92 | leukocyte aggregation (GO:0070486) | 2.77088043 |
| 93 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.76799770 |
| 94 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.76450494 |
| 95 | negative regulation of adaptive immune response (GO:0002820) | 2.75558564 |
| 96 | mature B cell differentiation involved in immune response (GO:0002313) | 2.73555808 |
| 97 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.73329341 |
| 98 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.71494963 |
| 99 | regulation of platelet aggregation (GO:0090330) | 2.70940836 |
| 100 | positive regulation of interferon-beta production (GO:0032728) | 2.69174300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.78009380 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.33367908 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.81470940 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.71285181 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.49619553 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.43021321 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.34902655 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.25249912 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.24917158 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.04443690 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.97045535 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.94775166 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.90206642 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83007719 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.80059128 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.79748275 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.50603608 |
| 18 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.43549546 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.40548375 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.23004308 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.22969671 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.19600347 |
| 23 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.17725436 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.05840112 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.05130776 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.04013527 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 2.00167773 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.93869187 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.83091695 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.82925602 |
| 31 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.78063813 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75629998 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75539478 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.73585228 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.66196562 |
| 36 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.61585096 |
| 37 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.60839664 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.57702997 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56493770 |
| 40 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.53415595 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53046322 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.50104402 |
| 43 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.49349752 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46427600 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.44932376 |
| 46 | MAF_26560356_Chip-Seq_TH1_Human | 1.42513141 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.42119178 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40961564 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38779116 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33315437 |
| 51 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32932113 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.31833763 |
| 53 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.31635540 |
| 54 | GATA2_19941826_ChIP-Seq_K562_Human | 1.31570057 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30143646 |
| 56 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28060021 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22915473 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18083462 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15541155 |
| 60 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12009879 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11464548 |
| 62 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11210726 |
| 63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11079471 |
| 64 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10572660 |
| 65 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10373858 |
| 66 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.09163111 |
| 67 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06429049 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02744156 |
| 69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02311394 |
| 70 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01313911 |
| 71 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01273312 |
| 72 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97469210 |
| 73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95466040 |
| 74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94961131 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94660039 |
| 76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93454181 |
| 77 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92839904 |
| 78 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.92553008 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90652378 |
| 80 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89626196 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89059359 |
| 82 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.88656889 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88235377 |
| 84 | MYC_22102868_ChIP-Seq_BL_Human | 0.84866660 |
| 85 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.83366916 |
| 86 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82109650 |
| 87 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.81895125 |
| 88 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.80540670 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79516972 |
| 90 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78522610 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78479948 |
| 92 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.77817712 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77178860 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.76659002 |
| 95 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.76595381 |
| 96 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76122951 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76006182 |
| 98 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.74706879 |
| 99 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71089512 |
| 100 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.70782668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.70887862 |
| 2 | MP0003303_peritoneal_inflammation | 4.42658661 |
| 3 | MP0000569_abnormal_digit_pigmentation | 3.38844366 |
| 4 | MP0003436_decreased_susceptibility_to | 3.35129379 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.02275611 |
| 6 | MP0002419_abnormal_innate_immunity | 2.66589557 |
| 7 | MP0008260_abnormal_autophagy | 2.64640492 |
| 8 | MP0005451_abnormal_body_composition | 2.58830195 |
| 9 | MP0003828_pulmonary_edema | 2.58510751 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.27421962 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.25980927 |
| 12 | MP0001800_abnormal_humoral_immune | 2.23296311 |
| 13 | MP0003656_abnormal_erythrocyte_physiolo | 2.22043404 |
| 14 | MP0005025_abnormal_response_to | 2.19576849 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.13100211 |
| 16 | MP0009785_altered_susceptibility_to | 2.11292656 |
| 17 | MP0000685_abnormal_immune_system | 2.08378657 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.03528273 |
| 19 | MP0002723_abnormal_immune_serum | 2.03404575 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.02338943 |
| 21 | MP0001545_abnormal_hematopoietic_system | 1.95610322 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 1.95610322 |
| 23 | MP0009278_abnormal_bone_marrow | 1.94220878 |
| 24 | MP0002420_abnormal_adaptive_immunity | 1.92366430 |
| 25 | MP0001819_abnormal_immune_cell | 1.89820060 |
| 26 | MP0009764_decreased_sensitivity_to | 1.86463137 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.81431375 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.80491861 |
| 29 | MP0006082_CNS_inflammation | 1.78510059 |
| 30 | MP0004510_myositis | 1.77191690 |
| 31 | MP0004947_skin_inflammation | 1.77067698 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.74951702 |
| 33 | MP0005387_immune_system_phenotype | 1.74829229 |
| 34 | MP0001790_abnormal_immune_system | 1.74829229 |
| 35 | MP0008004_abnormal_stomach_pH | 1.68842862 |
| 36 | MP0004883_abnormal_blood_vessel | 1.67094751 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.65813125 |
| 38 | MP0001853_heart_inflammation | 1.60908917 |
| 39 | MP0002332_abnormal_exercise_endurance | 1.59485171 |
| 40 | MP0002132_abnormal_respiratory_system | 1.55713129 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.53850610 |
| 42 | MP0002405_respiratory_system_inflammati | 1.53778943 |
| 43 | MP0003075_altered_response_to | 1.51696895 |
| 44 | MP0005671_abnormal_response_to | 1.50188882 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.50168978 |
| 46 | MP0002398_abnormal_bone_marrow | 1.49108710 |
| 47 | MP0005164_abnormal_response_to | 1.47856379 |
| 48 | MP0001851_eye_inflammation | 1.46586417 |
| 49 | MP0000716_abnormal_immune_system | 1.45242453 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.43409523 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.37824107 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.35922265 |
| 53 | MP0003221_abnormal_cardiomyocyte_apopto | 1.34865077 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.34315590 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.32019874 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.27323290 |
| 57 | MP0004130_abnormal_muscle_cell | 1.23947830 |
| 58 | MP0002722_abnormal_immune_system | 1.23221390 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.17279907 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.15282897 |
| 61 | MP0003045_fibrosis | 1.15082211 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.14564950 |
| 63 | MP0004381_abnormal_hair_follicle | 1.14455652 |
| 64 | MP0002429_abnormal_blood_cell | 1.14183323 |
| 65 | MP0004484_altered_response_of | 1.13793261 |
| 66 | MP0003787_abnormal_imprinting | 1.12767248 |
| 67 | MP0003690_abnormal_glial_cell | 1.12380056 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.12282711 |
| 69 | MP0008469_abnormal_protein_level | 1.11135261 |
| 70 | MP0005310_abnormal_salivary_gland | 1.07980332 |
| 71 | MP0002006_tumorigenesis | 1.06591893 |
| 72 | MP0003866_abnormal_defecation | 1.03161941 |
| 73 | MP0000604_amyloidosis | 1.01407774 |
| 74 | MP0003195_calcinosis | 0.99496438 |
| 75 | MP0000858_altered_metastatic_potential | 0.98454313 |
| 76 | MP0003091_abnormal_cell_migration | 0.97507626 |
| 77 | MP0005166_decreased_susceptibility_to | 0.92235265 |
| 78 | MP0003448_altered_tumor_morphology | 0.91582644 |
| 79 | MP0005666_abnormal_adipose_tissue | 0.90419004 |
| 80 | MP0005174_abnormal_tail_pigmentation | 0.89947361 |
| 81 | MP0009763_increased_sensitivity_to | 0.89373375 |
| 82 | MP0002138_abnormal_hepatobiliary_system | 0.86658030 |
| 83 | MP0003252_abnormal_bile_duct | 0.86524274 |
| 84 | MP0000703_abnormal_thymus_morphology | 0.85480827 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.85432830 |
| 86 | MP0000249_abnormal_blood_vessel | 0.84036915 |
| 87 | MP0008057_abnormal_DNA_replication | 0.78558434 |
| 88 | MP0002102_abnormal_ear_morphology | 0.76955125 |
| 89 | MP0002009_preneoplasia | 0.75459990 |
| 90 | MP0005376_homeostasis/metabolism_phenot | 0.73734953 |
| 91 | MP0003183_abnormal_peptide_metabolism | 0.73246426 |
| 92 | MP0000343_altered_response_to | 0.72994154 |
| 93 | MP0005390_skeleton_phenotype | 0.69075877 |
| 94 | MP0005266_abnormal_metabolism | 0.66436366 |
| 95 | MP0001663_abnormal_digestive_system | 0.63176421 |
| 96 | MP0005535_abnormal_body_temperature | 0.62943457 |
| 97 | MP0003632_abnormal_nervous_system | 0.62843599 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 0.62570647 |
| 99 | MP0009115_abnormal_fat_cell | 0.62435510 |
| 100 | MP0000609_abnormal_liver_physiology | 0.59492709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 5.79493993 |
| 2 | Optic neuritis (HP:0100653) | 5.48543041 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 5.48543041 |
| 4 | Orchitis (HP:0100796) | 5.31224922 |
| 5 | Recurrent abscess formation (HP:0002722) | 5.30692142 |
| 6 | Myositis (HP:0100614) | 5.20896461 |
| 7 | Eczematoid dermatitis (HP:0000976) | 5.14026188 |
| 8 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.75417877 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.54601657 |
| 10 | Stomatitis (HP:0010280) | 4.27176406 |
| 11 | Gingival bleeding (HP:0000225) | 4.18426687 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 4.17937999 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.16852146 |
| 14 | Keratoconjunctivitis sicca (HP:0001097) | 3.97727335 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.92352479 |
| 16 | Arterial thrombosis (HP:0004420) | 3.73649761 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.71318331 |
| 18 | Keratoconjunctivitis (HP:0001096) | 3.67749001 |
| 19 | Recurrent skin infections (HP:0001581) | 3.65864095 |
| 20 | Peritonitis (HP:0002586) | 3.57030873 |
| 21 | Gingivitis (HP:0000230) | 3.55899261 |
| 22 | Prolonged bleeding time (HP:0003010) | 3.34093302 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.31595709 |
| 24 | Spontaneous hematomas (HP:0007420) | 3.26985124 |
| 25 | T lymphocytopenia (HP:0005403) | 3.22231102 |
| 26 | Amyloidosis (HP:0011034) | 3.16883554 |
| 27 | Epistaxis (HP:0000421) | 3.15792814 |
| 28 | Abnormality of T cell number (HP:0011839) | 3.12284054 |
| 29 | Meningitis (HP:0001287) | 2.98913513 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.97460928 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 2.97460928 |
| 32 | Vasculitis (HP:0002633) | 2.95310839 |
| 33 | Hemoptysis (HP:0002105) | 2.94117154 |
| 34 | Slow saccadic eye movements (HP:0000514) | 2.88643391 |
| 35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.83342057 |
| 36 | Encephalitis (HP:0002383) | 2.82347566 |
| 37 | Chest pain (HP:0100749) | 2.81517329 |
| 38 | Gangrene (HP:0100758) | 2.79584624 |
| 39 | Subacute progressive viral hepatitis (HP:0006572) | 2.76881015 |
| 40 | Leukocytosis (HP:0001974) | 2.74918987 |
| 41 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72752683 |
| 42 | Obstructive lung disease (HP:0006536) | 2.72752683 |
| 43 | Pulmonary embolism (HP:0002204) | 2.71666575 |
| 44 | Anorexia (HP:0002039) | 2.65414434 |
| 45 | Urticaria (HP:0001025) | 2.65308405 |
| 46 | Episodic fever (HP:0001954) | 2.64375918 |
| 47 | Papillary thyroid carcinoma (HP:0002895) | 2.58783637 |
| 48 | Abnormality of the peritoneum (HP:0002585) | 2.54960317 |
| 49 | Autoimmune thrombocytopenia (HP:0001973) | 2.51433503 |
| 50 | Myocardial infarction (HP:0001658) | 2.44615449 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.43235555 |
| 52 | Recurrent viral infections (HP:0004429) | 2.43087607 |
| 53 | Autoimmune hemolytic anemia (HP:0001890) | 2.39063741 |
| 54 | Cellulitis (HP:0100658) | 2.38603935 |
| 55 | Postural instability (HP:0002172) | 2.38096867 |
| 56 | Abnormality of the endocardium (HP:0004306) | 2.34719816 |
| 57 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.34486415 |
| 58 | Increased IgE level (HP:0003212) | 2.28822919 |
| 59 | Periodontitis (HP:0000704) | 2.26048661 |
| 60 | Vertigo (HP:0002321) | 2.24881456 |
| 61 | Acute hepatic failure (HP:0006554) | 2.18743128 |
| 62 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.18302174 |
| 63 | Abnormal platelet volume (HP:0011876) | 2.16006665 |
| 64 | Thrombophlebitis (HP:0004418) | 2.15700053 |
| 65 | Resting tremor (HP:0002322) | 2.12436546 |
| 66 | Difficulty running (HP:0009046) | 2.11946014 |
| 67 | Abnormality of T cells (HP:0002843) | 2.11449409 |
| 68 | Muscle fiber splitting (HP:0003555) | 2.11326954 |
| 69 | Inflammation of the large intestine (HP:0002037) | 2.10996901 |
| 70 | Viral hepatitis (HP:0006562) | 2.10345902 |
| 71 | Acute myeloid leukemia (HP:0004808) | 2.09856408 |
| 72 | Hematochezia (HP:0002573) | 2.05375372 |
| 73 | Colitis (HP:0002583) | 2.04261394 |
| 74 | Eosinophilia (HP:0001880) | 2.03827988 |
| 75 | Abnormality of the fingertips (HP:0001211) | 2.03596837 |
| 76 | Gastrointestinal inflammation (HP:0004386) | 2.00937668 |
| 77 | Polyneuropathy (HP:0001271) | 2.00549505 |
| 78 | Interstitial pulmonary disease (HP:0006530) | 2.00167863 |
| 79 | Abnormality of the pleura (HP:0002103) | 1.98104363 |
| 80 | Increased cerebral lipofuscin (HP:0011813) | 1.96673831 |
| 81 | Glomerulopathy (HP:0100820) | 1.96571186 |
| 82 | Granulocytopenia (HP:0001913) | 1.93687175 |
| 83 | Keratitis (HP:0000491) | 1.92567225 |
| 84 | Alveolar cell carcinoma (HP:0006519) | 1.91495456 |
| 85 | Abnormality of iron homeostasis (HP:0011031) | 1.83975772 |
| 86 | Conjunctival telangiectasia (HP:0000524) | 1.83934454 |
| 87 | Stomach cancer (HP:0012126) | 1.83484192 |
| 88 | Osteomyelitis (HP:0002754) | 1.83117854 |
| 89 | Increased mean platelet volume (HP:0011877) | 1.82438782 |
| 90 | Menorrhagia (HP:0000132) | 1.81393372 |
| 91 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.78854687 |
| 92 | Petechiae (HP:0000967) | 1.78624223 |
| 93 | Systemic lupus erythematosus (HP:0002725) | 1.78071718 |
| 94 | Amaurosis fugax (HP:0100576) | 1.76153190 |
| 95 | Increased serum ferritin (HP:0003281) | 1.75984472 |
| 96 | Acne (HP:0001061) | 1.73361329 |
| 97 | Facial diplegia (HP:0001349) | 1.72204346 |
| 98 | Neonatal hypoglycemia (HP:0001998) | 1.70735216 |
| 99 | Disinhibition (HP:0000734) | 1.70295166 |
| 100 | Hypochromic microcytic anemia (HP:0004840) | 1.70283465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.68292713 |
| 2 | IRAK4 | 3.43812720 |
| 3 | MAP2K3 | 3.36094857 |
| 4 | BLK | 3.09710320 |
| 5 | IRAK1 | 2.82654024 |
| 6 | TAOK3 | 2.60496504 |
| 7 | IRAK2 | 2.52322045 |
| 8 | IKBKE | 2.48381862 |
| 9 | MAP3K14 | 2.39827300 |
| 10 | CSK | 2.12187022 |
| 11 | PIK3CG | 2.04051558 |
| 12 | BMPR2 | 1.93832938 |
| 13 | JAK3 | 1.88336518 |
| 14 | MAP3K3 | 1.77469364 |
| 15 | GRK6 | 1.75925606 |
| 16 | TYK2 | 1.75519128 |
| 17 | ZAP70 | 1.69919131 |
| 18 | TXK | 1.68881716 |
| 19 | MAP3K2 | 1.65531720 |
| 20 | SYK | 1.64843035 |
| 21 | MAP4K1 | 1.62492036 |
| 22 | PRPF4B | 1.61899962 |
| 23 | FES | 1.59893070 |
| 24 | FGR | 1.53763430 |
| 25 | FRK | 1.51321804 |
| 26 | MAP3K6 | 1.49775885 |
| 27 | SGK2 | 1.48192956 |
| 28 | MATK | 1.47495207 |
| 29 | TBK1 | 1.47208521 |
| 30 | MAP3K1 | 1.45611680 |
| 31 | BTK | 1.39737929 |
| 32 | FGFR3 | 1.36040153 |
| 33 | HCK | 1.34472148 |
| 34 | JAK2 | 1.31369053 |
| 35 | BRD4 | 1.31095042 |
| 36 | EPHB1 | 1.26793200 |
| 37 | ACVR1B | 1.24690515 |
| 38 | KSR2 | 1.20581412 |
| 39 | SGK3 | 1.19937586 |
| 40 | TAOK1 | 1.16670261 |
| 41 | IKBKB | 1.15059648 |
| 42 | JAK1 | 1.14669097 |
| 43 | TEC | 1.13672244 |
| 44 | WNK1 | 1.11272181 |
| 45 | LYN | 1.07634598 |
| 46 | PTK2B | 1.03810499 |
| 47 | CAMK1D | 1.01056381 |
| 48 | MARK3 | 0.95762102 |
| 49 | TAOK2 | 0.95119571 |
| 50 | KIT | 0.94668684 |
| 51 | TRPM7 | 0.89076264 |
| 52 | TNK2 | 0.88994827 |
| 53 | EPHA3 | 0.87784584 |
| 54 | LCK | 0.85181287 |
| 55 | MARK2 | 0.83929696 |
| 56 | PIM1 | 0.81713595 |
| 57 | MAP3K5 | 0.78944508 |
| 58 | CHUK | 0.78584108 |
| 59 | MAP3K11 | 0.77591925 |
| 60 | SGK223 | 0.76984193 |
| 61 | SGK494 | 0.76984193 |
| 62 | TGFBR2 | 0.76380664 |
| 63 | CDK12 | 0.74268380 |
| 64 | MAP3K13 | 0.73300636 |
| 65 | STK4 | 0.72781162 |
| 66 | YES1 | 0.72735192 |
| 67 | PDK1 | 0.72609248 |
| 68 | ERN1 | 0.71313811 |
| 69 | ITK | 0.70200317 |
| 70 | CAMK1G | 0.70193473 |
| 71 | LRRK2 | 0.69786684 |
| 72 | MAPK7 | 0.67456575 |
| 73 | ERBB2 | 0.66880172 |
| 74 | IRAK3 | 0.66112032 |
| 75 | STK11 | 0.64991022 |
| 76 | PDPK1 | 0.61749824 |
| 77 | RAF1 | 0.61599716 |
| 78 | CSF1R | 0.61239766 |
| 79 | KSR1 | 0.58532470 |
| 80 | NLK | 0.57869198 |
| 81 | MAP2K4 | 0.56611967 |
| 82 | AKT3 | 0.55792826 |
| 83 | PRKAA2 | 0.53619156 |
| 84 | MAP3K7 | 0.52145209 |
| 85 | HIPK2 | 0.49402187 |
| 86 | SGK1 | 0.47845106 |
| 87 | EGFR | 0.45562902 |
| 88 | MAP2K6 | 0.43653671 |
| 89 | GRK5 | 0.43494980 |
| 90 | PDGFRB | 0.43464626 |
| 91 | DMPK | 0.43171497 |
| 92 | CAMK4 | 0.42428091 |
| 93 | GRK7 | 0.42062323 |
| 94 | RET | 0.39519205 |
| 95 | LATS1 | 0.38907525 |
| 96 | FYN | 0.38709663 |
| 97 | CDC42BPA | 0.38368531 |
| 98 | PRKCQ | 0.36295816 |
| 99 | MOS | 0.33719104 |
| 100 | MAPK12 | 0.33298035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.04122683 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.85588413 |
| 3 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.63313142 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.37549029 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.31632820 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.29947431 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.14237784 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.09095507 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.06728823 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.88215120 |
| 11 | Malaria_Homo sapiens_hsa05144 | 1.87847320 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.83911435 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81450502 |
| 14 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.76306775 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.69590621 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.63894119 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.60910688 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.56964918 |
| 19 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.52780382 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50734051 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.50254293 |
| 22 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.47716138 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47535268 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43560386 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42577907 |
| 26 | Platelet activation_Homo sapiens_hsa04611 | 1.42414254 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40093547 |
| 28 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.32606917 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.32220342 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.30414845 |
| 31 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.25790746 |
| 32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23705666 |
| 33 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.19439701 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.18523721 |
| 35 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16652495 |
| 36 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.14611427 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.14601020 |
| 38 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.12180547 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11647256 |
| 40 | Amoebiasis_Homo sapiens_hsa05146 | 1.05532227 |
| 41 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02697718 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99240146 |
| 43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.98576096 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97621886 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 0.96443959 |
| 46 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93952517 |
| 47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.93733274 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93196673 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92531394 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91796038 |
| 51 | Insulin resistance_Homo sapiens_hsa04931 | 0.91454570 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87939495 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87140094 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 0.85796298 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.85268854 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.84374899 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83077735 |
| 58 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.82405095 |
| 59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.82020578 |
| 60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81958029 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81223927 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79883455 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79682223 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78424935 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77847805 |
| 66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77315609 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76241511 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74645934 |
| 69 | Allograft rejection_Homo sapiens_hsa05330 | 0.73648081 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72915505 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.72747139 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71280913 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.69590337 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69367398 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68491319 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68212061 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67904330 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67098901 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65164100 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.64992187 |
| 81 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62341403 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60525526 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59521194 |
| 84 | Prostate cancer_Homo sapiens_hsa05215 | 0.58914018 |
| 85 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.57746691 |
| 86 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.56741063 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.55050929 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53730692 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52789097 |
| 90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52622088 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50581783 |
| 92 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45400478 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43251833 |
| 94 | Asthma_Homo sapiens_hsa05310 | 0.43065415 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42508504 |
| 96 | Long-term potentiation_Homo sapiens_hsa04720 | 0.41208858 |
| 97 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40725251 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39243058 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37037358 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36916875 |

